Pharmaceutical companies Bayer, Intendis and Intraserv have filed a patent infringement lawsuit against Glenmark after it applied to market a generic version of rosacea treatment Finacea.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Bayer, Finacea, Intendis, Intraserv, generic, USPTO, patent extension
